Rocket Lab Just Hit 93 Electron Launches. Is the Neutron Timeline Still the Stock's Biggest Risk?

Rocket Lab successfully flew Electron for the 93rd time, but investor focus remains on Neutron, whose first launch has slipped from an initial 2024 target to projections that now push it to 2027 (with further delay risk). The article notes ongoing Neutron development delays have weighed on the stock, while the analyst community still values RKLB at $116/share—over 70% above the current price. Rocket Lab also highlighted customer momentum (Kepler Communications becoming a paying Neutron customer) and business diversification via prior acquisitions, though the near-term stock reaction appears driven primarily by Neutron execution risk.

Analysis

RKLB is trading like an execution-credibility asset, not a normal growth story. The reliable small launcher is useful but not enough to justify much multiple expansion because the addressable market is narrow; the real equity value is the option on medium-lift access, and each slip pushes that option further out while competitors keep converting customer intent into recurring launch manifests. In launch, delay is not neutral: it gives customers time to standardize around incumbents and makes it harder for a new entrant to win the first repeat orders.

The second-order effect is that the revenue mix may look diversified, but the market will keep valuing the company on the least-de-risked leg. That means any “non-launch” progress likely gets discounted until it is tied to repeatable cash flow, while negative Neutron headlines can compress the multiple faster than operating results can rebuild it. Near term, the main beneficiaries are the incumbents that can absorb deferred medium-lift demand and the satellite operators that monetize the ecosystem without bearing development risk.

The contrarian view is that the selloff may be overdoing the near-term optics if management can prove a credible test cadence and maintain customer commitments. But the burden of proof is high: until there is a firm launch window and evidence of integration/testing progress, this remains a story of pushed-out monetization. Falsifiers are simple: a credible sub-12-month Neutron schedule, additional paying launch commitments, or a step-change in gross margin/cash burn that shows the rest of the business can carry the valuation on its own.

Key Decisions for Investors

• RKLB: avoid adding on strength over the next 1-3 months; if already long, hedge with 3-6 month put spreads or covered calls because the stock is still event-driven and vulnerable to another timeline slip.
• RKLB: only re-risk on a confirmed Neutron milestone path (test campaign, integrated systems progress, or a firm launch date inside 12 months); otherwise treat it as a trading vehicle, not a core hold.
• Pair trade idea: long a cash-generative satellite infrastructure proxy vs. short RKLB for 1-3 months to isolate execution risk from sector enthusiasm; thesis fails if Rocket Lab secures multiple medium-lift contracts or advances first-flight timing meaningfully.
• Set an alert on any formal Neutron schedule revision or launch-cadence update; a clean de-risking event could trigger a sharp squeeze, so shorts should be sized as event risk, not structural shorts.